Advanced CRC in 2021 is treated according to genetic alterations including the microsatellite stable (MSS) groups with KRAS/NRAS mutations, BRAF mutations, and KRAS/NRAS/BRAF WT, or microsatellite unstable (MSI) [5]. Here, KRAS is linked to colorectal carcinoma.